JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB153987

Anti-LCLAT1 抗体

Anti-LCLAT1 antibody

Be the first to review this product! Submit a review

|

(2 Publications)

Rabbit Polyclonal LCLAT1 antibody. Suitable for WB and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human LCLAT1 aa 150 to C-terminus.

別名を表示する

AGPAT8, ALCAT1, LYCAT, UNQ1849/PRO3579, LCLAT1, Lysocardiolipin acyltransferase 1, 1-acylglycerol-3-phosphate O-acyltransferase 8, Acyl-CoA:lysocardiolipin acyltransferase 1, 1-AGP acyltransferase 8, 1-AGPAT 8

1 Images
Western blot - Anti-LCLAT1 antibody (AB153987)
  • WB

Unknown

Western blot - Anti-LCLAT1 antibody (AB153987)

10% SDS PAGE

All lanes:

Western blot - Anti-LCLAT1 antibody (ab153987) at 1/500 dilution

Lane 1:

HeLa whole cell lysate at 20 µg

Lane 2:

HeLa membrane lysate at 20 µg

Predicted band size: 49 kDa

false

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

WB

applications

免疫原

Recombinant Fragment Protein within Human LCLAT1 aa 150 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q6UWP7

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/3000", "WB-species-notes": "<p></p>" } } }
style
left-column
style
left-column

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
pH: 7 Preservative: 0.01% Thimerosal (merthiolate) Constituents: PBS, 20% Glycerol (glycerin, glycerine), 1% BSA
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle
style
left-column

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Lysocardiolipin acyltransferase 1 (LCLAT1) also known as monolysocardiolipin acyltransferase (MLCL AT-1) is an enzyme with a mass of approximately 58 kDa. LCLAT1 resides primarily in the mitochondria and plays a significant role in phospholipid metabolism by catalyzing the reacylation of monolysocardiolipin (MLCL) to cardiolipin (CL). This function is critical for maintaining mitochondrial membrane structure and function. Expression of LCLAT1 occurs in various tissues with notable presence in heart and skeletal muscle where high energy demand correlates with mitochondrial activity.
Biological function summary

LCLAT1 functions within the lipid remodeling pathway specific to the mitochondria and is an important player in the maintenance of mitochondrial function and energy metabolism. This enzyme acts independently not as part of a larger protein complex. LCLAT1 ensures the proper composition of cardiolipin which is essential for the optimal performance of respiratory chain complexes and cellular energy homeostasis.

Pathways

The enzyme LCLAT1 plays a vital role in lipid metabolism particularly the remodeling pathway of cardiolipin in mitochondria. This pathway is vital for the functionality of the electron transport chain an important element in cellular respiration. LCLAT1 interconnects with Tafazzin (TAZ) another enzyme critical in cardiolipin biosynthesis and remodeling highlighting its participation in maintaining mitochondrial health and efficient aerobic energy supply.

Alterations in LCLAT1 function have connections to mitochondrial diseases due to its role in cardiolipin remodeling. Disruptions in its activity may relate to Barth syndrome a genetic disorder linked to defects in cardiolipin metabolism. LCLAT1's association with Tafazzin (TAZ) further implicates it in the disorder as both proteins are essential for proper cardiolipin function and mitochondrial integrity.
style
left-column
style
left-column

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

ターゲットの情報

Exhibits acyl-CoA : lysocardiolipin acyltransferase (ALCAT) activity; catalyzes the reacylation of lyso-cardiolipin to cardiolipin (CL), a key step in CL remodeling (By similarity). Recognizes both monolysocardiolipin and dilysocardiolipin as substrates with a preference for linoleoyl-CoA and oleoyl-CoA as acyl donors (By similarity). Also exhibits 1-acyl-sn-glycerol-3-phosphate acyltransferase activity (AGPAT) activity; converts 1-acyl-sn-glycerol-3- phosphate (lysophosphatidic acid or LPA) into 1,2-diacyl-sn-glycerol-3- phosphate (phosphatidic acid or PA) by incorporating an acyl moiety at the sn-2 position of the glycerol backbone (PubMed : 16620771). Possesses both lysophosphatidylinositol acyltransferase (LPIAT) and lysophosphatidylglycerol acyltransferase (LPGAT) activities (PubMed : 19075029). Required for establishment of the hematopoietic and endothelial lineages (By similarity).
See full target information LCLAT1
style
left-column

文献 (2)

Recent publications for all applications. Explore the full list and refine your search

European journal of medical research 28:209 PubMed37393390

2023

Abnormal expression of fission and fusion genes and the morphology of mitochondria in eutopic and ectopic endometrium.

Applications

Unspecified application

Species

Unspecified reactive species

Chaoshuang Ye,Pei Chen,Bingning Xu,Yang Jin,Yongchao Pan,Tianyu Wu,Yongjiang Du,Jingxia Mao,Ruijin Wu

Free radical biology & medicine 158:171-180 PubMed32726688

2020

Aerobic exercise alleviates oxidative stress-induced apoptosis in kidneys of myocardial infarction mice by inhibiting ALCAT1 and activating FNDC5/Irisin signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Fangnan Wu,Zhuo Li,Mengxin Cai,Yue Xi,Zujie Xu,Zezhou Zhang,Hangzhuo Li,Wanyu Zhu,Zhenjun Tian
View all publications
style
left-column
style
left-column
style
right-column

代替製品

Primary Antibodies

AB122197

Anti-LCLAT1 antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LCLAT1 antibody (AB122197)

  • 0
  • 0

組合せ製品

Secondary Antibodies

AB150077

Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488)

Immunocytochemistry/ Immunofluorescence - Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (AB150077)

  • 5
  • 20
Primary Antibodies

AB214034

Anti-LPCAT1 antibody [EPR19882]

RabMAb|Recombinant

Flow Cytometry (Intracellular) - Anti-LPCAT1 antibody [EPR19882] (AB214034)

  • 0
  • 0
Primary Antibodies

AB168479

Anti-PTPMT1 antibody

Western blot - Anti-PTPMT1 antibody (AB168479)

  • 0
  • 0
Primary Antibodies

AB92547

Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker

BOND RX™ Validated|KO Validated|RabMAb|Recombinant|Lab Essentials|20ul selling size|Advanced Validation

Multiplex immunohistochemistry - Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker (AB92547)

  • 5
  • 92

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com